The cost of Alzheimer's disease in China and re-estimation of costs worldwide
Jianping Jia,Cuibai Wei,Shuoqi Chen,Fangyu Li,Yi Tang,Wei Qin,Lina Zhao,Hongmei Jin,Hui Xu,Fen Wang,Aihong Zhou,Xiumei Zuo,Liyong Wu,Ying Han,Yue Han,Liyuan Huang,Qi Wang,Dan Li,Changbiao Chu,Lu Shi,Min Gong,Yifeng Du,Jiewen Zhang,Junjian Zhang,Chunkui Zhou,Jihui Lv,Yang Lv,Haiqun Xie,Yong Ji,Fang Li,Enyan Yu,Benyan Luo,Yanjiang Wang,Shanshan Yang,Qiumin Qu,Qihao Guo,Furu Liang,Jintao Zhang,Lan Tan,Lu Shen,Kunnan Zhang,Jinbiao Zhang,Dantao Peng,Muni Tang,Peiyuan Lv,Boyan Fang,Lan Chu,Longfei Jia,Serge Gauthier
DOI: https://doi.org/10.1016/j.jalz.2017.12.006
Abstract:Introduction: The socioeconomic costs of Alzheimer's disease (AD) in China and its impact on global economic burden remain uncertain. Methods: We collected data from 3098 patients with AD in 81 representative centers across China and estimated AD costs for individual patient and total patients in China in 2015. Based on this data, we re-estimated the worldwide costs of AD. Results: The annual socioeconomic cost per patient was US $19,144.36, and total costs were US $167.74 billion in 2015. The annual total costs are predicted to reach US $507.49 billion in 2030 and US $1.89 trillion in 2050. Based on our results, the global estimates of costs for dementia were US $957.56 billion in 2015, and will be US $2.54 trillion in 2030, and US $9.12 trillion in 2050, much more than the predictions by the World Alzheimer Report 2015. Discussion: China bears a heavy burden of AD costs, which greatly change the estimates of AD cost worldwide.